Equities

Shandong Pharmaceutical Glass Co Ltd

600529:SHH

Shandong Pharmaceutical Glass Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)25.03
  • Today's Change0.14 / 0.56%
  • Shares traded6.44m
  • 1 Year change-4.10%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,5052,2621,015
Total Receivables, Net1,7341,5701,203
Total Inventory1,0551,210878
Prepaid expenses738762
Other current assets, total179192177
Total current assets5,5465,3213,335
Property, plant & equipment, net3,4823,1712,844
Goodwill, net------
Intangibles, net254260198
Long term investments0.050.050.05
Note receivable - long term------
Other long term assets------
Total assets9,3198,7846,410
LIABILITIES
Accounts payable766696722
Accrued expenses645169
Notes payable/short-term debt696842714
Current portion long-term debt/capital leases------
Other current liabilities, total201175174
Total current liabilities1,7271,7641,679
Total long term debt000
Total debt696842714
Deferred income tax------
Minority interest------
Other liabilities, total585960
Total liabilities1,7841,8231,739
SHAREHOLDERS EQUITY
Common stock664664595
Additional paid-in capital2,6872,687913
Retained earnings (accumulated deficit)4,1843,6113,162
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity7,5356,9624,670
Total liabilities & shareholders' equity9,3198,7846,410
Total common shares outstanding664664595
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.